FLG rs1780496: Skin Barrier Function and Allergy Predisposition
rs1780496 is a single-nucleotide polymorphism located within the filaggrin (FLG) gene on chromosome 1q21.3. The FLG locus encodes key structural proteins necessary for the integrity and hydration of the skin's outer epidermal barrier. Certain alleles at this variant have been evaluated for associations with altered skin barrier permeability, atopic dermatitis risk, and downstream allergic sensitization.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| CC | Homozygous for the common reference allele at this position. Individuals with this genotype typically exhibit baseline population-level genetic risk for filaggrin-related epidermal barrier disruption. | Informational |
| CT | Heterozygous for the variant allele. In epidemiological research, carrying one copy of the minor allele has been statistically linked to a modest increase in susceptibility to dry skin and allergic sensitization, though overall penetrance is low. | Higher attention |
| TT | Homozygous for the minor variant allele. This is a less frequent genotype associated in limited association studies with potential differences in epidermal barrier integrity, though it remains non-diagnostic for atopic disease. | Higher attention |
Genomic Context and the Filaggrin Gene
The rs1780496 variant is situated within the filaggrin (FLG) gene locus, which resides in the Epidermal Differentiation Complex (EDC) on chromosome 1q21.3. Filaggrin (filament-aggregating protein) is initially synthesized as a large precursor polyprotein called profilaggrin within the granular layer of the epidermis. During terminal differentiation of keratinocytes, profilaggrin is enzymatically cleaved into functional filaggrin monomers. These monomers bundle keratin intermediate filaments together, creating a tightly cross-linked structural matrix that forms the stratum corneum—the outermost protective shield of human skin. As these flattened corneocytes mature, filaggrin is further degraded into hygroscopic free amino acids that form natural moisturizing factors (NMF), essential for maintaining hydration and an acidic skin surface pH.
Role in Skin Barrier Integrity and the Atopic March
When the FLG gene carries variants that compromise protein quantity or function, the stratum corneum becomes structurally fragile and prone to elevated transepidermal water loss (TEWL). A leaky epidermal barrier facilitates the abnormal penetration of external environmental triggers, including aeroallergens, harsh detergents, microbes like Staphylococcus aureus, and food antigens. In immunogenetically predisposed individuals, this percutaneous allergen entry triggers dermal inflammatory cascades and epicutaneous immune sensitization. This process frequently manifests clinically as atopic dermatitis (eczema) in early childhood. Subsequent sensitization can promote what clinicians term the 'atopic march'—a progressive immunological trajectory leading from eczema to allergic rhinitis, food allergies, and asthma.
Evaluating the Scientific Evidence for rs1780496
While classical loss-of-function null mutations in FLG (such as p.R501X and c.2282del4) have definitive, robust clinical evidence linking them to severe eczema and ichthyosis vulgaris, the evidence specifically supporting rs1780496 remains limited. In human genetic catalogs, rs1780496 is categorized as a trait-associated marker exhibiting statistical correlation rather than definitive clinical pathogenicity. Many population association studies evaluate rs1780496 in linkage disequilibrium with other EDC variants or as part of broader filaggrin haplotype panels. Findings across smaller cohort studies show modest odds ratios for allergic phenotypes, meaning having a risk allele slightly increases statistical susceptibility rather than directly causing barrier disruption in every carrier.
Population Frequency and Diversity
Genetic variation across the FLG locus shows pronounced ancestral divergence. In populations of European descent, the minor allele frequency (MAF) for rs1780496 typically ranges between 0.05 and 0.10 (5% to 10%). By contrast, filaggrin variant architecture varies dramatically in non-European ancestries; for instance, distinct Asian and African populations harbor unique spectrums of FLG missense, nonsense, and frameshift alleles that differ entirely from those frequent in European cohorts. Consequently, risk estimates derived from European GWAS or candidate gene studies may not accurately predict skin barrier traits or allergic risks in multi-ancestry individuals, underscoring the ongoing need for diverse cohort sequencing.
What Consumers Can and Cannot Conclude
Having information about your rs1780496 genotype offers an interesting look into your personal genomic background, but it is not a clinical diagnosis of eczema or allergies. Atopic dermatitis is a complex, multifactorial trait shaped by dozens of genes alongside environmental exposures, climate, water hardness, and immune system triggers. A person carrying the minor allele may have resilient, healthy skin throughout life, while an individual with two typical alleles might develop severe allergic conditions. Genetic test results for rs1780496 should never be used to initiate prescription dermatological treatments or self-diagnose allergies; any clinical concerns regarding skin rashes or allergic reactions should be evaluated by a dermatologist or allergist.
How common is this variant?
The minor allele frequency (MAF) for rs1780496 is estimated at approximately 0.05 to 0.10 in European populations, while prevalence data across broader global ancestries remains limited due to high diversity in the filaggrin locus.
Frequently asked questions
Does having the rs1780496 variant mean I will get eczema?
No. Carrying the variant allele only confers a modest statistical association with skin barrier characteristics. Eczema is a multifactorial condition influenced by many genetic loci, immune responses, and environmental factors, so many carriers never develop any skin problems.
What is the atopic march?
The atopic march refers to the typical clinical progression of allergic diseases often starting in infancy with atopic dermatitis (eczema). Impaired skin barrier function can allow allergens to penetrate the skin, triggering immune pathways that may later lead to food allergies, allergic rhinitis, and asthma.
Is rs1780496 considered a loss-of-function mutation in FLG?
No, rs1780496 is generally classified as a common single-nucleotide variant with limited evidence of disease causation, distinct from the well-characterized null or truncating loss-of-function mutations (like R501X or 2282del4) that severely ablate filaggrin protein production.
Can skincare or moisturizers counteract genetic filaggrin variations?
While topical products cannot change your genetics, evidence-based dermatological routines—such as using gentle cleansers, applying ceramide-rich moisturizers, and protecting the skin barrier—can support skin hydration and reduce transepidermal water loss regardless of your genotype.
Sources & further reading
Educational information only, last refreshed 9/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1780496?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29